Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
2

Year Published

2017
2017
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 92 publications
0
9
0
2
Order By: Relevance
“…In 2013 Rodrigues et al , 39 on behalf of the Brazilian Society of Bone Marrow Transplantation, developed recommendations on the use of HSCT as a treatment for SSc.…”
Section: State Of the Art On Clinical Practice Guidelinesmentioning
confidence: 99%
“…In 2013 Rodrigues et al , 39 on behalf of the Brazilian Society of Bone Marrow Transplantation, developed recommendations on the use of HSCT as a treatment for SSc.…”
Section: State Of the Art On Clinical Practice Guidelinesmentioning
confidence: 99%
“…Autologous HSCT has been employed in the treatment of some forms of MS, even though it is not considered to be the standard treatment of the disease [1,2,3]. There are still controversies about its indication, which range between total skepticism and opinions about the unethical behavior of neurologists not offering it to patients with MS [4].…”
Section: Discussionmentioning
confidence: 99%
“…The risk of transplant-related mortality in HSCT for MS was conventionally considered very high but has declined since 2001 to less than 1.3% [2,3,4,5,6]; this may be due to the result of the changes in the conditioning regimens, thus reducing toxicity. Recent data, with more than 700 autologous transplants for MS in Europe, showed an overall survival (OS) of 92% in 5 years and a progression-free survival of 46%, the main cause of mortality and morbidity being the recurrence of the autoimmune disease [2,3,4,5,6]. The consensus provides an indication of HSCT in patients with progressive MS unresponsive to conventional therapy and Expanded Disability Status Scale (EDSS) [1] between 3 and 6.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Every three years, a clinical guidelines meeting occurs, and one of the subjects is autoimmune diseases. In addition to the annual SBTMO meeting, reports and position papers are prepared and published from these events[ 41 ]. Among the most cited autoimmune diseases recommended for HSCT are multiple sclerosis, systemic sclerosis, and CD.…”
Section: And Hsct In Brazilmentioning
confidence: 99%